A functional disorder is a medical condition that impairs the normal function, but withoutmajororganiccausesuchasirritationorinflammationandwheretheorganor part of the body looks completely normal under medical examination. The accumulation of abnormalities that limit body functions is a major risk factor for patients with irritable bowel syndrome (IBS), defined as a gastrointestinal disorder with abdominal pain or discomfort that is associated with a change in bowel habit. Often, this disorder is accompanied by the concomitant decline in cognitive or motor performance. Pain that in somepatientsisoutofproportiontoidentifiablepathologyisthemostimmediateand dramatic consequence of IBS and is responsible for a highly negative impact on quality of life and substantial workforce loss. For patients with IBS, the most common comorbid diagnoses include painful bladder syndrome (PBS) or chronic pelvic pain (CPP). Cells of theaffectedtissuesmayinteractincell-to-cellmannermessagesthroughthetransferof hormones,cytokines,andothermediatorsthatinfluencenormalfunctioning.Thecomplex interplay and balance between these diverse mediators, ageing, genetic background, and environmental factors may ultimately determine the outcome of the progression of the functional disorder. On a cellular level, these responses are highly complex, involving a vast array of enzymes and receptors of virtually every class, directing recruitment of many types of cells to recover the healthy state. Indeed, a balance between the messengerswiththeinherentredundancyofthedifferentbodysystemsmakestherapeutic intervention of functional disorders a considerable challenge.
Introduction
The response properties of pelvic extrinsic primary afferent nerves (EPANs) play an important role in etiology of irritable bowel syndrome (IBS). Hypersensitivity of visceral mechanoreceptorscouldresultfromexcessiveproductionofmodulatoryneurotransmitters. In addition to direct stimulation of stretch-activated channels on primary afferent neurons locatedindorsalrootganglia(DRG),chemicalsproducedbydifferenttargetcells(suchas smoothmusclecellsandinterstitialcellsofCajal)inresponsetostretchorinflammationplay an important role in the neuromodulation of nociception. The incidence of persistent, episodic, or chronic visceral pain is more prevalent in females, which also suggests hormonal regulation.Despiteextensiveresearchofthepropertiesofpelvicandsplanchnicafferentnerves,little is known about the mechanisms underlying normal and pathological signal transduction pathwaysunderlyingmanyfunctionaldiseases.Despiteconsiderableeffortsbythescientific community and the pharmaceutical industry to develop novel pharmacological treatments aimed at chronic visceral pain, the traditional approaches to identifying and evaluating novel drugsforthistargethavelargelyfailedtotranslateintoeffectiveIBStreatments [1] .Abetter understandingoftheseprocesseshasdirectimplicationsforthedevelopmentofmoreeffectivetherapies.Duringthelastdecade,weidentifiedthatDRGneuronscanbeaffectedbyATP, NO,estrogen,andothermediatorsproducingneuronalhyper-ordesensitizationthatmay unravel the enigma of the development of chronic pelvic pain associated with IBS. Moreover, ourrecentdatathatestrogencangateprimaryafferentresponsetomodulatenociceptionsupport the idea about involvement of peripheral central system in etiology of a wide range of the functionalandinflammatorygastrointestinaldiseases[2].
Role of EPANs in the mechanisms of visceral neurotransduction and modulation
Pelvic nerve afferent fibers innervating the visceral organs of the lower colon have been wellcharacterized(reviewedinRef. [3] ). In general, during colonic distension, a large num-berofpelvicEPANsshowstaticlevelsofdischarge.Stretchesthatleadtotheopeningof stretch-activated (SA) channels on the plasma membrane lead to the selective or nonselective opening of different cation and anion channels in nodose ganglia and DRG neurons.Thus,dependingonthecelltypeandchanneltype,EPANsactivationmayresultin hyperpolarization, depolarization, or primarily Ca 2+ influx.ThefunctionofSAchannelsin theplasmamembranediffersbetweenvariouscelltypes.InfluxofCa 2+ may repolarize the plasma membrane via activation of K ca channels and inactivating of voltage-gated calcium channels(VGCCs),andthusinfluenceadaptationratesofsensoryneuronsduringongoing stimulations.
The cell bodies of primary visceral spinal afferent neurons are located in the lumbosacral (L1-S1) DRGs that transmit information about chemical or mechanical stimulation from the periphery to the spinal cord. Nociceptors are small-to medium-size DRG neurons whose peripheral processes detect potentially damaging physical and chemical stimuli. Until recently, ATP release from nonneuronal cells was thought to be exclusively as result of injury. ItisnowclearthatcertainintegralmembraneproteinscontainanATP-bindingcassettesothis neurotransmittercanactassignalingmoleculemodulatingsensoryafferentnerveterminals. SixP2XreceptorsareexpressedinDRGs.Significantly,theP2X3receptorisfoundexclusively
in a subset of small diameter capsaicin sensitive peripheral sensory neurons (presumably nociceptors) [4] . Today, multiple lines of evidence suggest that ATP signaling via P2X receptorscontributetodifferentpainphenotypes,thereforeP2Xantagonistsmaybeusefulanalgesics.TheavailabilityofP2Xreceptor-specificantagonistsalsoholdsthepromiseofrevealing the cellular and molecular neurobiology underlying pain states underlying functional diseases [5] . With sufficiently high levels ofATP, P2X and SA channels (which has a greater permeability for Ca 2+ thanNa + ) would depolarize nerve terminals directly producing action potentialsandleadingtosensationofpain.Ontheotherhand,theresponseofEPANsmay betonicallyinhibitedbyNOproducedbyperipheralnerveterminals.Theperipheralsensitizationofnervefibersistransientdependingonthedurationofstimuliandthepresenceof visceral(colonic)inflammation.
Estrogen receptors and visceral nociception associated with functional diseases
Changes in pain perception and variations of symptoms throughout the menstrual cycle, as wellassexualintercoursetriggeringsymptomsinasignificantportionoffemalesdiagnosed with irritable bowel syndrome (IBS), painful bladder syndrome (PBS), chronic pelvic pain (CPP), and other function syndromes, points to a connection with sex steroids. Several lines ofevidenceindicatethat17β-estradiol(E2)directlyinfluencethefunctionsofprimaryafferentneurons.Bothsubtypesofestrogenreceptors(ERαandERβ)arepresentinDRGneurons includingthesmall-diameterputativenociceptors [4] . In vitro, ATP-sensitive DRG neurons respondtoE2 [6, 7] ,whichcorrelatedwellwiththeideathatvisceralafferentsareE2sensitive: (i)visceralpainisaffectedbyhormonallevelincyclingfemales;(ii)therearesexdifferences intheprevalenceoffunctionaldisordersinvolvingtheviscera;and(iii)putativevisceralaffer-entsfitintothepopulationofDRGneuronsthataresensitivetoE2 [7] . These data suggest thatinadditiontotheCNSactions,E2canactintheperipherytomodulatenociception [6, 7] . E2modulatescellularactivitybyalteringionchannelopening,G-proteinsignaling,andactivationoftrophicfactor-likesignaltransductionpathways.Theseeffectshavebeenascribed to membrane-associated receptors [8] . The results from our laboratory and others indicate thatE2actsinDRGneuronstomodulateL-typeVGCCandthroughgroupIImetabotropic glutamatereceptors [6] .
E2hasasignificantroleinmodulatingvisceralsensitivity,indicatingthatE2alterationsin sensory processing may underlie sex-based differences in functional pain symptoms [9] .
Indeed in most clinical studies, women report more severe pain levels, more frequent pain, andlongerdurationofpainthanmen [10] .LittleisknownaboutE2-mediatedmechanisms inperipheralnervoussystem,butthefactthatDRGneuronsexpressERsandrespondtoE2 treatmentsuggestthattheyareapotentialtargetformediatingnociception.E2modulationof nociceptive response depends on the type of pain, its durations, and the involvement of other nociceptive-mediated mechanisms.
E2(bothshort-termandlong-termexposure)significantlydecreasedthenociceptivesignal-inginviscerallylabeledDRGneurons [6, 7] . Thus, in addition to central regulation, estrogen mayaffectnociceptionassociatedwithIBSperipherally.
Primary afferent neurons and viscero-visceral cross-sensitization: emerging model for functional gastrointestinal disorders
Most of the current literature pertains to specific functional syndromes defined by medical subspecialties. These include: IBS (gastroenterology); CPP (gynecology); PBS ( urology); fibromyalgia (rheumatology); and others. Many reports described the substantial overlaps between two or more of these syndromes [11, 12] . Moreover, clinical presentations of functionalsyndromeslackaspecificpathologyintheaffectedorganbutmayrespondtoa viscero-visceral cross-sensitization in which increased nociceptive input from an inflamed organ(i.e.,uterus)sensitizesneuronsthatreceiveconvergentinputfromanunaffectedorgan (i.e., colon or bladder). The site of visceral cross-sensitivity is unknown.
Recent studies from our laboratory demonstrated that hormonal modulation of visceral inputs of primary afferent nociceptors located in the dorsal root ganglia (DRG) is responsible for changes observed in the perception of pain during the etiology of functional pain syndromes [2] .IndividualssufferingfromCPPfrequentlyhavepainemanatingfromseveral visceral organs. Viscero-somatic and viscero-visceral hyperalgesia and allodynia lead to the perception of pain spreading from an initial site to adjacent areas. Patients with CPP may atfirsthaveonlyonesourceofpaininthepelvis,butnumerousmechanismsinvolvingthe central and peripheral nervous systems may result in the development of painful sensations in adjacent organs, such as IBS being associated with lower colonic pain.
Summary
Similar to other chronic diseases, a multicomponent conceptual model of IBS, which involves physiologic, cognitive and behavior factors will be necessary for developing new therapies. Thedifferentsystemssuchasneuroendocrineregulation,painmodulation,andautonomic responsewillaffectascendingaminergicsystems (Figure 1) .
From a public health perspective, a substantial impact on our knowledge of nociceptive diseases such IBS will help achieve a deeper understanding of data presented in clinical aspects of these symptoms. Only a thorough understanding of the mechanism implicatedinthesephenomenacantrulycontributetothedesigningofnewandmoreefficient therapies.
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